Notably, Wnt5a is overexpressed specifically in basal breast cancer cell lines (MDA-MB-231 and BCap-37), which harbor a mesenchymal phenotype and a high proportion of CSCs. This evidence concerns the gene WNT5A and breast carcinoma.